TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A prospective study of 194 patients found that genicular artery embolization using dissolvable microspheres was associated with reduced knee pain and improved mobility for at least 12 months. At the one-year follow-up, 80% of patients assessed reported clinically meaningful pain relief. The single-center study does not establish that the procedure slows arthritis or replaces knee replacement.
A single-center study of 194 people with knee osteoarthritis found that genicular artery embolization using rapidly dissolving particles was associated with meaningful pain relief for many patients at one year. The minimally invasive procedure targets selected abnormal blood vessels around the knee and may offer another option for people who have not benefited enough from standard care and cannot or do not want knee replacement; the findings do not show that it prevents joint damage or can replace surgery.
The study, published in the journal Radiology, examined patients whose knee pain had persisted despite at least three months of conventional treatment. That care included physical therapy, anti-inflammatory medication and injections. Researchers reported substantial reductions in pain and improvements in mobility, with benefits continuing for at least 12 months. Among patients assessed at the one-year follow-up, 80% reported clinically meaningful pain relief.
The procedure, called genicular artery embolization (GAE), is performed by an interventional radiologist. A thin catheter is guided through an artery to selected small vessels around the knee, where tiny particles are delivered to reduce blood flow in abnormal vessels. The study used gelatin-based microspheres designed to dissolve within hours. The technique does not involve an open knee operation or replacing the joint, and it aims to preserve normal circulation while targeting specific vessels.
The study included 114 women and 80 men, with a median age of 69 and a median body mass index of 28.4. It was prospective, meaning the researchers followed participants over time, but it took place at one center. The report describes an association between treatment and improved symptoms; the available findings do not establish how GAE compares with other treatments in a randomized trial or how well outcomes will hold beyond the reported follow-up.
A Nonsurgical Option After Standard Care
The results speak to a treatment gap for people whose symptoms remain difficult to manage after non-surgical care but for whom knee replacement is unsuitable or unwanted. Osteoarthritis pain can make walking, climbing stairs and standing harder, so a procedure associated with relief over a year could matter to patients weighing the limits and risks of their current options.
GAE differs from treatments aimed directly at the joint surface: it targets blood vessels linked to inflammation and pain signaling. But the study does not establish that it is a cure, a substitute for proven care, or a way to avoid replacement indefinitely. Its reported benefits are symptom outcomes, not proof that cartilage damage was reversed or that disease progression was slowed. Patients should discuss the evidence, possible risks and alternatives with qualified clinicians.
Products Worth Considering
Fitbit Versa 4 Fitness Smartwatch – Black/Graphite
Therabody Theragun Mini 3rd Generation Massage Gun, Black
Oral-B iO Series 9 Limited Rechargeable Electric Toothbrush with 7 Cleaning Modes
As an affiliate, we earn on qualifying purchases.
How the Vessel-Targeting Procedure Works
Knee osteoarthritis involves gradual deterioration of cartilage, but persistent pain can also involve inflammation and changes in tissues around the joint. The study’s rationale is that abnormal vessel growth near an inflamed joint may interact with sensory nerves that transmit pain. GAE seeks to reduce that activity by blocking selected small arteries, rather than treating cartilage directly.
Researchers have examined different embolic materials for the procedure, including temporary agents and particles that remain in vessels. The team in this study used resorbable microspheres designed to dissolve within hours. The report presents this material choice as part of the treatment approach; it does not, on the information provided, establish that the particles are safer or more effective than other materials.
Osteoarthritis is common and can limit everyday activity. The World Health Organization is cited in the source report as estimating that more than 365 million adults worldwide have knee osteoarthritis. Typical care begins with measures such as exercise-based physical therapy and medication, with injections also used; knee replacement may be considered when symptoms remain severe. Not everyone is a candidate for surgery, and personal preferences also shape treatment decisions.
“We believe these results carry real weight because they come from real-world data.”
— Florian Nima Fleckenstein, M.D.
Questions About Durability and Disease Change
The findings are encouraging for symptom relief but leave several questions open. The report describes a prospective study at one center; the supplied material does not establish that participants were randomly assigned to GAE or a comparison treatment. Without that information and comparative results, it is difficult to determine how much improvement came from the procedure itself versus other factors or how it performs against established options.
The results reported here extend to at least 12 months. Longer-term durability, the frequency and nature of complications, and which patients are most likely to benefit are not specified in the available material. Nor did the study establish that GAE slows osteoarthritis progression, protects cartilage or delays the need for eventual knee replacement. Those questions require further evidence.
Further Evidence and Longer Follow-Up
The next useful steps would be longer follow-up and studies comparing GAE with standard care or other appropriate treatments. Such research could clarify whether the reported pain and mobility improvements persist, how risks compare, and whether results differ by the severity of arthritis or patients’ prior treatments.
For now, the reported findings add a potential option for discussion, not a new standard established by this study alone. People considering GAE should ask an interventional radiologist and their usual arthritis care team about their suitability, the evidence for their situation, potential complications, alternatives and the possibility that further treatment may still be needed.
Key Questions
What is genicular artery embolization?
Genicular artery embolization (GAE) is a catheter-based procedure in which a clinician delivers tiny particles to selected blood vessels around the knee. The aim is to reduce flow through abnormal vessels associated with inflammation and pain, while preserving normal circulation.
How long did pain relief last in the study?
The study reported that benefits continued for at least 12 months. At the one-year follow-up, 80% of patients assessed reported clinically meaningful pain relief. The report does not establish how long benefits last beyond that period.
Does the procedure repair cartilage or stop arthritis?
That has not been shown. The reported outcomes concern pain and mobility. The study did not demonstrate that GAE reverses cartilage damage or slows osteoarthritis progression.
Is GAE a replacement for knee replacement surgery?
The study describes GAE as a possible option for some people who have persistent symptoms and cannot or do not want joint replacement. It does not establish that the procedure can replace surgery for all patients or prevent a future operation.
Who should ask about the treatment?
People with ongoing knee osteoarthritis symptoms despite conventional care can ask their clinician whether GAE is appropriate for them. Suitability, risks, available alternatives and the limits of the current evidence should be reviewed with qualified specialists.
Source: rss
